Shares of Cronos Group Inc. (NASDAQ:CRON - Get Free Report) rose 4.9% on Wednesday . The company traded as high as $1.82 and last traded at $1.81. Approximately 2,056,364 shares were traded during mid-day trading, an increase of 40% from the average daily volume of 1,468,205 shares. The stock had previously closed at $1.72.
Cronos Group Stock Down 1.7 %
The firm has a market capitalization of $670.61 million, a price-to-earnings ratio of -13.38, a PEG ratio of 1.74 and a beta of 1.02. The stock's 50-day moving average price is $1.85 and its 200 day moving average price is $1.98.
Institutional Trading of Cronos Group
Several large investors have recently added to or reduced their stakes in CRON. Tidal Investments LLC raised its stake in Cronos Group by 4.4% during the third quarter. Tidal Investments LLC now owns 5,026,489 shares of the company's stock worth $11,008,000 after purchasing an additional 210,263 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Cronos Group by 5.1% in the 4th quarter. Dimensional Fund Advisors LP now owns 2,753,055 shares of the company's stock valued at $5,561,000 after acquiring an additional 132,536 shares during the period. Cannell Capital LLC acquired a new position in shares of Cronos Group in the 4th quarter worth approximately $3,323,000. Millennium Management LLC raised its holdings in shares of Cronos Group by 23.7% in the 4th quarter. Millennium Management LLC now owns 840,374 shares of the company's stock valued at $1,698,000 after buying an additional 161,163 shares during the period. Finally, Geode Capital Management LLC lifted its stake in Cronos Group by 6.4% during the 4th quarter. Geode Capital Management LLC now owns 546,700 shares of the company's stock worth $1,104,000 after acquiring an additional 33,121 shares in the last quarter. 8.71% of the stock is currently owned by hedge funds and other institutional investors.
About Cronos Group
(
Get Free Report)
Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.
Further Reading
Before you consider Cronos Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cronos Group wasn't on the list.
While Cronos Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
